Cell Cycle/Checkpoint

The cell cycle is consisted of 4 main phases: Gap 1 (G1), DNA replication (S), Gap 2 (G2), and mitosis (M). There are “checkpoints” mechanism regulates the transition between these phases, at the G1/S boundary, in the S-phase and during G2/M phases. Cell can only pass through these checkpoints when signaling factors are activated and free of DNA damage. Important proteins that control cell cycle events and checkpoints are cullins, cyclins, cyclin-dependent kinases (Cdks), p53 and their inhibitors etc. Cdks family (Cdk2, Cdk3, Cdk4 and Cdk6) are Ser/Thr kinases that regulate cell cycle progression in association with cyclin binding partners (cyclin D, cyclin E and cyclin A) during all four phases. p53 halts the cell cycle if the DNA is damaged and allowing time for DNA repair to progress; it can also initiate apoptosis if DNA damage is too severe to be repaired.
-   B1035 Dolastatin 10Target: Microtubules/TubulinsSummary: Antitumor agent B1035 Dolastatin 10Target: Microtubules/TubulinsSummary: Antitumor agent
-   A4119 AMG-900Summary: Aurora kinase inhibitor A4119 AMG-900Summary: Aurora kinase inhibitor
-   A3575 LY2835219 free baseSummary: CDK inhibitor A3575 LY2835219 free baseSummary: CDK inhibitor
-   B1294 SR-3677Target: ROCKSummary: Rho Kinase (ROCK-II) inhibitor B1294 SR-3677Target: ROCKSummary: Rho Kinase (ROCK-II) inhibitor
-   B7249 TCS 2312Summary: checkpoint kinase 1 (chk1) inhibitor B7249 TCS 2312Summary: checkpoint kinase 1 (chk1) inhibitor
-   B5604 TC-S 7005Summary: polo-like kinase 2 (PLK2) inhibitor B5604 TC-S 7005Summary: polo-like kinase 2 (PLK2) inhibitor
-   A4118 Hesperadin1 CitationTarget: Aurora KinasesSummary: Aurora B kinase inhibitor A4118 Hesperadin1 CitationTarget: Aurora KinasesSummary: Aurora B kinase inhibitor
-   A4395 10-DAB (10-Deacetylbaccatin)Summary: Precursor of antitumor compound Palitaxel and Docetaxel A4395 10-DAB (10-Deacetylbaccatin)Summary: Precursor of antitumor compound Palitaxel and Docetaxel
-   A3417 FlavopiridolTarget: Cyclin-Dependent KinasesSummary: Pan-cdk inhibitor A3417 FlavopiridolTarget: Cyclin-Dependent KinasesSummary: Pan-cdk inhibitor
-   B1293 Y-2763237 CitationTarget: ROCKSummary: ROCK inhibitor B1293 Y-2763237 CitationTarget: ROCKSummary: ROCK inhibitor
